Wound Care Biologics Market: Top 4 trends redefining the industry demand through 2025

Stakeholders have upped their investments in wound care biologics market share as the healing of wounds has gained impetus in the past several years. Biologic wound healing therapies boost the re-establishment of the repair mechanisms and include active biological agents that have antimicrobial, antioxidant, or anti-inflammatory features.

It is worth noting that biologic dressings ward off evaporative water loss, protein and electrolyte loss, heat loss and contamination. Wound care biologics develop a granular wound bed and enable autolytic debridement.

Notable government initiatives are likely to boost investments in the industry as stakeholders are gearing to expand their footfalls in the untapped areas. In the latest research report collated by Global Market Insights, Inc., wound care biologics market size is projected to surpass US$ 2.5 billion by 2025.

Some of the trends which are likely to redefine the industry outlook are delineated below:

Traction for Skin substitutes to soar

Recent years have witnessed a compelling presence of skin substitutes to replace the form and function of the skin. Traction for skin substitutes in chronic and non-healing ulcers, including diabetic neuropathic ulcers, pressure ulcers and vascular insufficiency ulcers will become more pronounced in the next five years.

With the innate ability of enhancing healing rates and mitigating complications in a range of skin wounds, such as wounds from ischemia, surgery, injuries, pressure, trauma and skin disorders, leading companies are expected to infuse funds in skin substitutes.

Trend for skin substitutes will be more pronounced given the impressive demand for the wound care biologics to reduce healing time, morbidity, post-operative contracture and enhance function.

Venous leg ulcers to boost revenue stream

With an uptick in venous leg ulceration among elderly population in North America and Europe, leading companies are gearing to bolster wound care biologics market revenue. Venous leg ulcers may be the result of the obstruction in the functioning of blood supply from legs to heart for purification.

Since the venous leg ulcers can derail blood supply, skin substitutes are highly sought-after in the treatment of veins in the leg. Venous leg ulcers segment was pegged at over US$195 million in 2018, significant growth is projected by 2025.

To access sample pages of this report titled, “Wound Care Biologics Market Size By Product (Skin Substitutes {Biological [Allograft, Xenograft], Synthetic}, Topical Agents), By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Surgical Wounds, Burns), By End-Use (Hospitals, Ambulatory Surgical Centers) Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents, please click on the link below:

https://www.gminsights.com/request-sample/detail/2925

Investments in hospitals wound care biologics to be more pronounced

Inclination for wound healing products in hospitals will potentially instill confidence among stakeholders. Poor blood flow and nerve damage have aggravated diabetes complication, thereby leading to a foot ulcer. According to the CDC report, around 34.2 million people have diabetes in the U.S.

With an upsurge in diabetic foot ulcers, surgical wounds, venous leg ulcers and burns, demand for wound healing products has surged in hospitals. According to the study, hospitals segment will grow at a healthy CAGR of over 8.8% through 2025.

North America to be replete with investments

A palpable rise in healthcare budget in the U.S. and Canada has triggered growth in North America wound care biologics market value. CDC further claims that around 88 million American adults have prediabetes. Moreover, an uptick in the proportion of older population and rampant chronic diseases have further signified the penetration of wound care biologics.

Asia Pacific is also likely to be replete with investments considering soaring cases of chronic diseases, including diabetes and AIDS. In addition, improving healthcare systems in India, China and Japan have augured well for stakeholders eyeing to expand their portfolios in APAC wound care biologics market.

About Global Market Insights, Inc.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com


 

Back to news